A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects

Conditions:		Morbid Obesity
Purpose:		This study will determine how morbid obesity affects the distribution and metabolism of the drug propofol. The investigators hypothesize that propofol will be distributed and metabolized differently in morbidly obese subjects as compared to normal weight subjects.
Study Summary:
Criteria:		Inclusion Criteria: - adult age (ages 18-70) - body mass index greater than 40 or between 20-25 - American Society of Anesthesiologists Class I, II, or III - undergoing elective surgical procedure requiring general anesthesia Exclusion Criteria: - evidence of cardiovascular or pulmonary disease - kidney or liver dysfunction - drug allergy to propofol - history of difficult airway - on prescribed or over the counter anxiolytics, antipsychotics, or sleeping aids - unable to speak or understand English
NCT ID:		NCT01591148
Primary Contact:		Principal Investigator Jerry Ingrande, M.D., M.S. Stanford University Jerry Ingrande, M.D., M.S. Phone: 650-723-7377 Email: jerryi@stanford.edu
Backup Contact:		N/A
Location Contact:		Stanford, California 94305 United States Jerry Ingrande, M.D., M.S. Phone: 650-723-7377 Email: jerryi@stanford.edu Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 22, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.